Arvada, CO, United States of America

Shadrach R Eubanks

This inventor holds 3 USPTO granted patents. Top assignees: Cortech, Inc., Core-Tech, Inc.. Active years: 1995-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shadrach R Eubanks. Retrieved from https://idiyas.com/inventor/shadrach-r-eubanks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Shadrach R Eubanks

Introduction

Shadrach R Eubanks is a notable inventor based in Arvada, Colorado. He has made significant contributions to the field of science and technology, particularly in the area of pharmacology. With a total of three patents to his name, Eubanks has demonstrated a commitment to innovation and research.

Latest Patents

Among his latest patents are two related to bradykinin antagonists. These patents focus on a bradykinin antagonist of a specific formula, showcasing his expertise in developing therapeutic agents that can potentially address various medical conditions.

Career Highlights

Eubanks has worked with several companies throughout his career, including Cortech, Inc. and Core-Tech, Inc. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the industry.

Collaborations

Some of his notable coworkers include John C Cheronis and Eric T Whalley. Their collaboration has likely fostered an environment of creativity and innovation, leading to advancements in their respective fields.

Conclusion

Shadrach R Eubanks is a distinguished inventor whose work in developing bradykinin antagonists and his collaborations with industry professionals highlight his impact on the field. His contributions continue to inspire future innovations in pharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…